NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Tumor-Derived FGF19

CompletedN/A

Sponsor: University of Central Florida

Conditions: Colorectal Cancer, Breast Cancer, Healthy

Countries: United States

Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* The study will enroll adult persons with breast cancer or colorectal cancer or no cancer (healthy controls) who are able to do a fasting blood draw.

(Pregnant women may choose to be in the study. The study procedures do not pose a risk to the safety of the unborn child or the woman.)

Exclusion Criteria:

* The study will not enroll persons who are unable or unwilling to provide informed consent.
* Adults unable to consent, individuals who are not yet adults, and prisoners will be excluded from this study.

Locations (1)

Orlando, Florida, United States